Adjuvant specific active lung cancer immunotherapy trials. Tumor-associated antigens
نویسندگان
چکیده
منابع مشابه
Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer
Prostate cancer (PCa) is the most common noncutaneous cancer diagnosis and the second leading cause of cancer-related deaths among men in the United States. Effective treatment modalities for advanced metastatic PCa are limited. Immunotherapeutic strategies based on T cells and antibodies represent interesting approaches to prevent progression from localized to advanced PCa and to improve survi...
متن کاملHuman Tumor Antigens and Cancer Immunotherapy
With the recent developments of adoptive T cell therapies and the use of new monoclonal antibodies against the immune checkpoints, immunotherapy is at a turning point. Key players for the success of these therapies are the cytolytic T lymphocytes, which are a subset of T cells able to recognize and kill tumor cells. Here, I review the nature of the antigenic peptides recognized by these T cells...
متن کاملInterleukin 1 as an Adjuvant for Active Specific Immunotherapy in a Murine Tumor Model1
Many vaccines are dependent on adjuvants to augment the immunizing process. The vaccines being developed for active specific immunotherapy of cancer have also usually included an adjuvant in the clinical studies. Several cytokines have been identified which are participants in the immune response to new antigenic stimulation. We investigated the potential of intcrleukin 1 (IL-1 ) to serve as an...
متن کاملInterleukin 1 as an adjuvant for active specific immunotherapy in a murine tumor model.
Many vaccines are dependent on adjuvants to augment the immunizing process. The vaccines being developed for active specific immunotherapy of cancer have also usually included an adjuvant in the clinical studies. Several cytokines have been identified which are participants in the immune response to new antigenic stimulation. We investigated the potential of interleukin 1 (IL-1) to serve as an ...
متن کاملExtent and location of tumor infiltrating lymphocytes in microsatellite stable colon cancer predict outcome to adjuvant active specific immunotherapy
PURPOSE To determine the prognostic and predictive value of tumor-infiltrating lymphocytes (TIL) in colon cancer in a cohort of patients who previously took part in a trial on adjuvant active specific immunotherapy (ASI). EXPERIMENTAL DESIGN We determined the number and location of CD3 and CD8 positive T cells in archival tumor samples of 106 colon cancers. We correlated stromal and epithelia...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1987
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(19870915)60:6<1249::aid-cncr2820600616>3.0.co;2-i